Signup Crypto ETF Stocks News

What's Going On With CrowdStrike Shares Friday? - CrowdStrike Holdings ( NASDAQ:CRWD )

The DOJ and SEC is reportedly investigating CrowdStrike's $32 million deal with Carahsoft. The deal between CrowdStrike and Carahsoft, a technology distributor, aimed to provide cybersecurity tools to the IRS.

Source: www.benzinga.com
February 21, 2025 | 18:09:46
Category: News

Smart Money Is Betting Big In MSTR Options - MicroStrategy ( NASDAQ:MSTR )

Deep-pocketed investors have adopted a bullish approach towards MicroStrategy MSTR, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

Source: www.benzinga.com
February 21, 2025 | 18:15:43
Category: News

Bitcoin Reserve With 1 Million BTC Could Offset $21 Trillion National Debt By 2049, Expert Says

VanEck proposes a strategic bitcoin reserve, accumulating 1 million BTC by 2029, to help offset $21 trillion in U.S. national debt by 2049. Prediction markets show rising odds of a federal Bitcoin reserve.

Source: www.benzinga.com
February 21, 2025 | 18:22:31
Category: News

This Booz Allen Hamilton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Akamai Techs ( NASDAQ:AKAM ) , Amalgamated Financial ( NASDAQ:AMAL )

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. JP Morgan analyst Rajat Gupta downgraded the rating for TrueCar, Inc.

Source: www.benzinga.com
February 21, 2025 | 18:27:09
Category: News

Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst - Insulet ( NASDAQ:PODD )

Insulet's Q4 revenue hit $597.5 million, up 17.2%, beating the $582.81 million consensus. Omnipod revenue climbed 16.9% to $585.7 million, with international sales up 33.5%. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, and real-time market insights.

Source: www.benzinga.com
February 21, 2025 | 18:28:14
Category: News

Looking At Freeport-McMoRan's Recent Unusual Options Activity - Freeport-McMoRan ( NYSE:FCX )

Financial giants have made a conspicuous bearish move on Freeport-McMoRan. Our analysis of options history for Freeport-McMoRan FCX revealed 19 unusual trades. Delving into the details, we found 31% of traders were bullish, while 57% showed bearish tendencies.

Source: www.benzinga.com
February 21, 2025 | 18:30:36
Category: News

Cleanspark Unusual Options Activity - Cleanspark ( NASDAQ:CLSK )

Whales with a lot of money to spend have taken a noticeably bearish stance on Cleanspark. Looking at options history for Cleanspark CLSK we detected 29 trades. If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations ...

Source: www.benzinga.com
February 21, 2025 | 18:30:42
Category: News

Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday? - Exelixis ( NASDAQ:EXEL )

Exelixis authorized a $500M stock repurchase, adding to the $1.2B returned to shareholders, with buybacks set to begin after Q2 2025. Q4 results topped estimates, with EPS at $0.55 ( vs. $0.43 consensus ) and revenue of $566.75M ( vs. $563.42M consensus ) .

Source: www.benzinga.com
February 21, 2025 | 18:30:43
Category: News

A Closer Look at Ford Motor's Options Market Dynamics - Ford Motor ( NYSE:F )

Financial giants have made a conspicuous bullish move on Ford Motor. Our analysis of options history for Ford Motor F revealed 9 unusual trades. Delving into the details, we found 66% of traders were bullish, while 33% showed bearish tendencies.

Source: www.benzinga.com
February 21, 2025 | 18:30:48
Category: News

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? - Guardant Health ( NASDAQ:GH )

Guardant Health Q4 adjusted EPS loss was $0.62, beating the consensus. Revenue rose 30% YoY to $201.8 million. FY25 revenue guidance is $850 million-$860 million vs. the $848.9 million consensus. Analysts raised price targets.

Source: www.benzinga.com
February 21, 2025 | 18:33:38
Category: News

© Natavest 2025 - 2026